Moxisylyte/Isosorbide Dinitrate

莫西赛利/硝酸异山梨酯

Report date: 2022/07/04 19:38:02

Base Information

Drug NameMoxisylyte/Isosorbide Dinitrate
Drug Alias Name莫西赛利-硝酸异山梨酯Moxisylyte-Isosorbide Dinitrate莫西赛利和硝酸异山梨酯Moxisylyte+Isosorbide DinitrateIsosorbide Dinitrate/Moxisylyte +[11] 
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsAtrial natriuretic peptide receptor agonists
TargetsAdrenergic receptors alpha-1Atrial natriuretic peptide receptor
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsYes Moxisylyte HydrochlorideIsosorbide Dinitrate
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVasolead
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVasolead (2012) Ltd
Active IndicationsN/A
Inactive IndicationsErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A